Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Papers
(The H4-Index of Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Issue Infomation132
Recent Advances in Wearable Sweat Sensor Development120
Issue Information93
Issue Information76
76
71
Issue Information60
Issue Information56
CRISPR‐Cas system manipulating nanoparticles signal transduction for cancer diagnosis56
Recent progress of electroactive interface in neural engineering55
Issue Information55
Nanoparticle‐peptide conjugates for bacterial detection and neutralization: Potential applications in diagnostics and therapy54
Renal clearable magnetic nanoparticles for magnetic resonance imaging and guided therapy54
Living virus‐based nanohybrids for biomedical applications54
Issue Information50
48
The importance of the IL‐1 family of cytokines in nanoimmunosafety and nanotoxicology47
Interfacially responsive electron transfer and matter conversion by polydopamine‐mediated nanoplatforms for advancing disease theranostics41
Current landscape of treating different cancers using nanomedicines: Trends and perspectives40
Better, Faster, Stronger: Accelerating mRNA‐Based Immunotherapies With Nanocarriers40
Magnetic modulation of lysosomes for cancer therapy37
A path toward the clinical translation of nano‐based imaging contrast agents36
3Delectron diffraction for structure determination of small‐molecule nanocrystals: A possible breakthrough for the pharmaceutical industry34
Shifting paradigm in electrochemical biosensing matrices comprising metal organic frameworks and their composites in disease diagnosis33
Challenges of enzyme therapy: Why two players are better than one33
Activated aggregation strategies to construct size‐increasing nanoparticles for cancer therapy32
Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy32
Nanovaccines to combat virus‐related diseases31
Exosomes in esophageal cancer: Promising nanocarriers in cancer progression, diagnosis, prognosis, and therapy30
Passive sweat wearable: A new paradigm in the wearable landscape toward enabling “detect to treat” opportunities30
0.51826500892639